Skip to main content
Equibles
RCUS $26.11 +1.08%
RCUS logo
RCUS · Arcus Biosciences, Inc.
Track RCUS — free

Use RCUS with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research RCUS.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$26.11 +0.28 (+1.08%)
S&P 600 member Russell 2000 member Rebalance outlook locked
Market Cap
$3.18B
Shares
127.33M
Volume · Sep 30 1.36M Avg daily vol (3M) 1.32M
All earnings calls

Earnings call · FY2022 Q1

Arcus Biosciences, Inc. (RCUS) Q1 2022 Earnings Call

Concluded May 9, 2022
May 9, 2022 0 turns
Period
FY2022 Q1
Runtime
—
Sources
2 artifacts
8-K 10-Q

Executive readout · one minute

Call research workspace

Read the call alongside every captured source. 8-K earnings release, 10-Q stay in one workspace.

Research coverage

2 live sources

Open each available source without leaving this research workspace.

Revenue $18.00M +90.3% YoY
Net income -$68.00M

Research materials

Open the source you need; every reader stays inside this workspace.

8-K earnings release Filed May 9, 2022 10-Q report Filed May 9, 2022

Quarter detail

How the reported period landed and where the business moved.

Revenue · products & services

Gilead Access Rights$8.32M +7.8% YoY
License and Development Services for All Gilead Programs$7.94M
Taiho Access Rights$1.75M +0% YoY
Full-screen source Call document

RCUS transcript alerts

Arcus Biosciences, Inc.

Create a free account or sign in to receive transcript alerts at your email address.

Continue to sign in
Read transcripts like this one from Claude, ChatGPT or your own code with the earnings call transcript API →